HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Haralabos P Kalofonos Selected Research

Peripheral Nervous System Diseases (PNS Diseases)

12/2014Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study.
9/2014Bortezomib-induced peripheral neurotoxicity: an update.
6/2014Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.
4/2014Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.
1/2014Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.
10/2013Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
1/2013Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
12/2011Epothilone-induced peripheral neuropathy: a review of current knowledge.
5/2011Vitamin E for preventing chemotherapy-induced peripheral neuropathy.
1/2009Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Haralabos P Kalofonos Research Topics

Disease

33Neoplasms (Cancer)
09/2015 - 02/2002
21Colorectal Neoplasms (Colorectal Cancer)
04/2015 - 02/2002
19Peripheral Nervous System Diseases (PNS Diseases)
12/2014 - 08/2005
15Breast Neoplasms (Breast Cancer)
06/2015 - 03/2003
8Carcinoma (Carcinomatosis)
10/2012 - 05/2006
7Neoplasm Metastasis (Metastasis)
01/2013 - 03/2003
5Disease Progression
10/2012 - 02/2002
5Glioma (Gliomas)
01/2011 - 02/2002
4Colonic Neoplasms (Colon Cancer)
01/2011 - 01/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 06/2008
2Ovarian Neoplasms (Ovarian Cancer)
01/2010 - 10/2008
2Anemia
06/2008 - 06/2003
2Pain (Aches)
06/2008 - 04/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2008 - 04/2006
2Stomach Neoplasms (Stomach Cancer)
01/2007 - 01/2006
2Diarrhea
01/2005 - 03/2003
2Sarcoma (Soft Tissue Sarcoma)
06/2004 - 01/2004
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2015
1Polyneuropathies (Polyneuropathy)
12/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Seminoma
01/2013
1Paresthesia (Dysesthesia)
12/2012
1Pelvic Neoplasms
02/2012
1Ganglion Cysts (Ganglion)
12/2011
1Pathologic Processes
10/2011
1Glioblastoma (Glioblastoma Multiforme)
01/2011

Drug/Important Bio-Agent (IBA)

12oxaliplatin (Eloxatin)FDA LinkGeneric
03/2015 - 01/2005
11Paclitaxel (Taxol)FDA LinkGeneric
04/2012 - 07/2005
7Leucovorin (Folinic Acid)FDA Link
10/2013 - 02/2002
7Fluorouracil (Carac)FDA LinkGeneric
10/2013 - 02/2002
5Messenger RNA (mRNA)IBA
10/2012 - 09/2007
5Carboplatin (JM8)FDA LinkGeneric
06/2010 - 12/2005
5Cisplatin (Platino)FDA LinkGeneric
10/2008 - 06/2004
4trastuzumab (Herceptin)FDA Link
06/2015 - 05/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 01/2009
4Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2015 - 11/2006
4Asp(5)- oxytocin (OXA)IBA
12/2014 - 10/2010
4XELOXIBA
10/2013 - 01/2005
4capecitabine (Xeloda)FDA Link
10/2013 - 01/2005
4Epirubicin (Ellence)FDA LinkGeneric
04/2012 - 01/2004
4docetaxel (Taxotere)FDA Link
01/2012 - 01/2004
4PlatinumIBA
01/2010 - 07/2005
3HormonesIBA
09/2015 - 03/2003
3TaxoidsIBA
06/2015 - 06/2008
3bevacizumabFDA Link
04/2015 - 02/2010
3Sodium Channels (Sodium Channel)IBA
10/2013 - 06/2008
3Estrogens (Estrogen)FDA Link
01/2013 - 03/2003
3Vitamin EFDA LinkGeneric
05/2011 - 09/2006
3irinotecan (Camptosar)FDA LinkGeneric
01/2011 - 03/2003
3lapatinib (GW572016)FDA Link
12/2010 - 05/2009
3sunitinib (Sutent)FDA Link
12/2010 - 11/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008 - 02/2002
2Formaldehyde (Formol)FDA Link
06/2015 - 07/2009
2ParaffinIBA
06/2015 - 07/2009
2Proteins (Proteins, Gene)IBA
01/2015 - 11/2006
2bortezomib (Velcade)FDA Link
09/2014 - 09/2008
2Platinum Compounds (Compounds, Platinum)IBA
01/2014 - 06/2008
2Phosphotransferases (Kinase)IBA
01/2014 - 11/2007
2Codon (Codons)IBA
01/2014 - 07/2010
2Matrix MetalloproteinasesIBA
01/2013 - 03/2003
2pegylated liposomal doxorubicinIBA
01/2010 - 01/2009
2AnthracyclinesIBA
01/2009 - 01/2007
1Plasminogen Activator Inhibitor 1IBA
06/2015
1Plasminogen Activators (Plasminogen Activator)IBA
06/2015
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2015
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2015
1Carbon MonoxideIBA
01/2015
1Thioctic Acid (Lipoic Acid)IBA
01/2015
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2015
1Epidermal Growth Factor (EGF)IBA
01/2015
1gemcitabineFDA Link
01/2015
1Vinca AlkaloidsIBA
01/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2014
1TamoxifenFDA LinkGeneric
01/2013
1Syndecan-4IBA
01/2013
1fulvestrant (Faslodex)FDA Link
01/2013
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2013
1Methotrexate (Mexate)FDA LinkGeneric
04/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2012
1RNA (Ribonucleic Acid)IBA
01/2012
1Protein Isoforms (Isoforms)IBA
01/2012
1NF-kappa B (NF-kB)IBA
01/2012
1Epothilones (Epothilone)IBA
12/2011
1Carisoprodol (Soma)FDA LinkGeneric
12/2011
1Excipients (Suspending Agents)IBA
12/2011
1AzoxymethaneIBA
10/2011
1Dextrans (Dextran)FDA Link
10/2011
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2011
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2011
1MicroRNAs (MicroRNA)IBA
10/2011
1Ribonucleases (Ribonuclease)IBA
10/2011
1Small Untranslated RNAIBA
10/2011
1DecorinIBA
01/2011
1Proteoglycans (Proteoglycan)IBA
01/2011
1Versicans (Versican)IBA
01/2011

Therapy/Procedure

38Drug Therapy (Chemotherapy)
09/2015 - 02/2002
4Adjuvant Chemotherapy
01/2011 - 03/2003
3Radiotherapy
02/2012 - 03/2003
2Craniotomy
05/2003 - 02/2002
1Immunotherapy
01/2014